TORREY COPE is an experienced, practical, and business-focused regulatory lawyer with scientific training and a passion for helping pharmaceutical, biotechnology, and medical technology companies solve their most challenging and cutting-edge FDA regulatory problems.
This work encompasses a full range of regulatory, enforcement, litigation, and transactional matters involving FDA issues, including matters involving clinical trials, marketing authorization, promotion, product safety, and other aspects of the product lifecycle. Many of his clients are working at the forefront of life sciences innovation in fields such as immunotherapy, regenerative medicine, genetic testing/next generation sequencing (NGS), digital health, and artificial intelligence/machine learning (AI/ML).
Torrey also collaborates regularly with Sidley colleagues in a variety of other practice areas to help clients with matters raising complex, multidisciplinary issues. This includes colleagues in Sidley’s Healthcare and Government Strategies practices. He is also a co-leader of Sidley’s Life Sciences Transactions initiative and regularly works hand-in-hand with colleagues in the firm’s Emerging Companies and Venture Capital, Private Equity, Capital Markets, M&A, and Technology and Life Sciences Transactions groups to provide clients with integrated, strategically-oriented regulatory advice on a wide variety of transactions.
Torrey has been recognized as a “Leading Partner” in Life Sciences (United States) by Legal 500 United States (2025) and a “Life Sciences Star” in the FDA Pharmaceutical category by LMG Life Sciences since 2016. He has also been recognized for FDA Law in The Best Lawyers in America since 2018.
Before law school, Torrey conducted research in molecular biology and worked as a quality control microbiologist for a major sterile drug manufacturer.